Korea's Pacific Pharmaceutical Awaits U.S. FDA Approval For OTC Product
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Pacific Pharmaceutical confirmed that the company is awaiting U.S. FDA approval for its over-the-counter product Ketotop, an analgesic/anti-inflammatory bandage for arthritis and for trauma patients